CN Patent

CN111574540B — 一种德高替尼的制备方法

Assigned to Yunnan Huapai Pharmaceutical Technology Co ltd · Expires 2023-08-29 · 3y expired

What this patent protects

本发明揭示了一种德高替尼(Delgocitinib)中间体的制备方法，以常见化合物为起始原料，依次进行溴代、酰化、环合、取代以及缩合还原等反应，使其制备过程原料易得、经济环保，为该原料药提供了一条新的制备途径，适于规模化工业生产。

USPTO Abstract

本发明揭示了一种德高替尼(Delgocitinib)中间体的制备方法，以常见化合物为起始原料，依次进行溴代、酰化、环合、取代以及缩合还原等反应，使其制备过程原料易得、经济环保，为该原料药提供了一条新的制备途径，适于规模化工业生产。

Drugs covered by this patent

Patent Metadata

Patent number
CN111574540B
Jurisdiction
CN
Classification
—
Expires
2023-08-29
Drug substance claim
No
Drug product claim
No
Assignee
Yunnan Huapai Pharmaceutical Technology Co ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.